SCHEMBL4585169

SCHEMBL4585169

CC(C)n1cc(-c2nc(-c3ccccc3)c(N)nc2-c2ccccc2)ccc1=O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 5/20 0.57
ADORA1 P30542 2/20 0.57
BMPR1B O00238 2/20 0.46
BMPR1A P36894 2/20 0.46
TGFBR1 P36897 2/20 0.46
ACVRL1 P37023 2/20 0.46
ACVR1 Q04771 2/20 0.46
PTGDR2 Q9Y5Y4 1/20 0.42
ATR Q13535 9/20 0.42
ADORA3 P0DMS8 1/20 0.38
ADORA2B P29275 1/20 0.38
CSNK1A1 P48729 1/20 0.38
CLK4 Q9HAZ1 1/20 0.38
LCK P06239 1/20 0.38
SRC P12931 1/20 0.38
KDR P35968 1/20 0.38
TEK Q02763 1/20 0.38
KDM4E B2RXH2 1/20 0.37
JAK2 O60674 1/20 0.37
GMNN O75496 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4583017 0.91 ADORA2A (0.54) ADORA2AADORA1BMPR1BBMPR1ATGFBR1
SCHEMBL4584817 0.90 ADORA2A (0.51) ADORA2AADORA1BMPR1BBMPR1ATGFBR1
SCHEMBL4584518 0.89 ADORA2A (0.53) ADORA2AADORA1BMPR1BBMPR1ATGFBR1
SCHEMBL4584746 0.89 ADORA2A (0.55) ADORA2AADORA1BMPR1BBMPR1ATGFBR1
SCHEMBL4585418 0.87 ADORA2A (0.51) ADORA2AADORA1BMPR1BBMPR1ATGFBR1
SCHEMBL4584555 0.87 ADORA2A (0.51) ADORA2AADORA1BMPR1BBMPR1ATGFBR1
SCHEMBL27667473 0.87 ADORA2A (0.51) ADORA2AADORA1BMPR1BBMPR1ATGFBR1
SCHEMBL4585009 0.87 ADORA2A (0.51) ADORA2AADORA1BMPR1BBMPR1ATGFBR1
SCHEMBL4584952 0.87 ADORA2A (0.51) ADORA2AADORA1BMPR1BBMPR1ATGFBR1
SCHEMBL4585211 0.87 ADORA2A (0.48) ADORA2AADORA1BMPR1BBMPR1ATGFBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7407961-B2 Pyrazine derivatives and pharmaceutical use thereof ASTELLAS PHARMA INC. (JP) 2008-08-05 US disclosed
US-20050113387-A1 Pyrazine derivatives and pharmaceutical use thereof FUJISAWA PHARMACEUTICAL CO. LTD. (JP) 2005-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113387-A1 Pyrazine derivatives and pharmaceutical use thereof ADORA2A, P2RX5, ADORA1 ADORA2A 1/4885ADORA1 3/4885BMPR1B 3464/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.